• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
CONTRAST-TO-NOISE RATIO IS A USEFUL PREDICTOR OF EARLY DISPLACEMENT OF LARGE SUBMACULAR HEMORRHAGE BY INTRAVITREAL SF6 GAS INJECTION.对比噪声比是预测眼内注入 SF6 气体对大黄斑下出血早期移位的有用指标。
2
Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.利用视网膜下鸡尾酒注射与气动移位治疗黄斑下出血的对比:一项真实世界的比较研究。
Ophthalmologica. 2024;247(2):118-132. doi: 10.1159/000537953. Epub 2024 Feb 26.
3
Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.玻璃体内重组组织纤溶酶原激活物联合六氟化硫治疗年龄相关性黄斑变性伴黄斑下出血:穿透血影。
Ophthalmologica. 2020;243(3):224-235. doi: 10.1159/000505752. Epub 2020 Jan 7.
4
Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.比较重组组织型纤溶酶原激活剂与气体经视网膜下和玻璃体内注射治疗湿性年龄相关性黄斑变性继发的黄斑下出血:治疗结果和简要文献复习。
Int Ophthalmol. 2021 Dec;41(12):4037-4046. doi: 10.1007/s10792-021-01976-x. Epub 2021 Jul 30.
5
The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.色素上皮脱离在接受玻璃体切除术以及视网膜下联合应用rtPA和抗VEGF治疗的伴有黄斑下出血的年龄相关性黄斑变性中的作用
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1115-1123. doi: 10.1007/s00417-017-3620-2. Epub 2017 Mar 9.
6
Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.黄斑下出血的气体置换联合视网膜下空气及组织型纤溶酶原激活剂:美国的初步经验
Ophthalmol Retina. 2018 Mar;2(3):180-186. doi: 10.1016/j.oret.2017.07.012. Epub 2017 Sep 28.
7
Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.眼内组织型纤溶酶原激活物、雷珠单抗联合气体注射治疗息肉样脉络膜血管病变伴黄斑下出血
Ophthalmology. 2016 Jun;123(6):1278-86. doi: 10.1016/j.ophtha.2016.01.035. Epub 2016 Mar 2.
8
Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.渗出性年龄相关性黄斑变性继发黄斑下出血治疗后视力提高的预后因素。
Eur J Ophthalmol. 2024 May;34(3):825-833. doi: 10.1177/11206721231202048. Epub 2023 Sep 16.
9
Can intravitreal tissue plasminogen activator and SF6 gas facilitate management of macular degeneration with photodynamic therapy?
Eur J Ophthalmol. 2008 Jul-Aug;18(4):591-4. doi: 10.1177/112067210801800415.
10
Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.早期手术移位黄斑下出血而不使用组织型纤溶酶原激活物:一年的结果。
Can J Ophthalmol. 2024 Oct;59(5):e582-e589. doi: 10.1016/j.jcjo.2023.10.005. Epub 2023 Nov 1.

引用本文的文献

1
Outcomes in the Treatment of Subretinal Macular Hemorrhage Secondary to Age-Related Macular Degeneration: A Systematic Review.年龄相关性黄斑变性继发视网膜下黄斑出血的治疗结局:一项系统评价
J Clin Med. 2024 Jan 9;13(2):367. doi: 10.3390/jcm13020367.

对比噪声比是预测眼内注入 SF6 气体对大黄斑下出血早期移位的有用指标。

CONTRAST-TO-NOISE RATIO IS A USEFUL PREDICTOR OF EARLY DISPLACEMENT OF LARGE SUBMACULAR HEMORRHAGE BY INTRAVITREAL SF6 GAS INJECTION.

作者信息

Ura Sawako, Miyata Manabu, Ooto Sotaro, Yasuhara Satoshi, Tamura Hiroshi, Ueda-Arakawa Naoko, Muraoka Yuki, Miyake Masahiro, Takahashi Ayako, Wakazono Tomotaka, Uji Akihito, Yamashiro Kenji, Tsujikawa Akitaka

机构信息

Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo Ku, Kyoto City, Kyoto Prefecture, Japan ; and.

Department of Ophthalmology, Red Cross Otsu Hospital, Otsu City, Japan .

出版信息

Retina. 2022 Apr 1;42(4):661-668. doi: 10.1097/IAE.0000000000003360.

DOI:10.1097/IAE.0000000000003360
PMID:35350046
Abstract

PURPOSE

To investigate predictors of early displacement of submacular hemorrhage (SMH) by simple intravitreal SF6 gas injection.

METHODS

This retrospective study included 16 eyes of 16 consecutive patients (age: 74.5 ± 7.7 years; 15 men) with large SMH treated with simple intravitreal SF6 gas before inception of subretinal tissue plasminogen activator injection at our institution. The SMH displacement was graded at 1-week posttreatment as 0, 1, or 2. Central retinal thickness, central choroidal thickness, SMH height, SMH area, disease duration, use of anticoagulant or antiplatelet drugs, and contrast-to-noise ratio (CNR) of SMH on optical coherence tomography images were recorded. Correlations between displacement grading and baseline parameter were analyzed.

RESULTS

Univariable correlation analysis revealed association of the 1-week displacement grading with the CNR (P = 0.004; r = -0.68) and SMH height (P = 0.03; r = -0.55). The CNR was most strongly associated with 1-week displacement on multivariable correlation analysis (P = 0.01; β = -0.60).

CONCLUSION

Findings of the present study showed that the CNR of SMH was a useful predictor of early displacement of large SMH after simple intravitreal SF6 gas injection. When vitrectomy with subretinal injection of tissue plasminogen activator is difficult in patients with large SMH, with low CNR on optical coherence tomography, simple intravitreal SF6 gas injection may be a treatment option.

摘要

目的

研究单纯玻璃体腔 SF6 气体注射治疗早期黄斑下出血(SMH)移位的预测因素。

方法

本回顾性研究纳入了 16 例(16 只眼)患者,这些患者均患有大 SMH,在本机构开始应用视网膜下组织纤溶酶原激活剂注射之前,接受了单纯玻璃体腔 SF6 气体注射治疗。治疗后 1 周,根据 SMH 移位程度将其分为 0 级、1 级或 2 级。记录中央视网膜厚度、中央脉络膜厚度、SMH 高度、SMH 面积、疾病持续时间、是否使用抗凝或抗血小板药物,以及光学相干断层扫描图像上 SMH 的对比噪声比(CNR)。分析移位分级与基线参数之间的相关性。

结果

单变量相关分析显示,1 周移位分级与 CNR(P = 0.004;r = -0.68)和 SMH 高度(P = 0.03;r = -0.55)有关。多变量相关分析显示,CNR 与 1 周移位关系最密切(P = 0.01;β = -0.60)。

结论

本研究结果表明,SMH 的 CNR 是单纯玻璃体腔 SF6 气体注射治疗后大 SMH 早期移位的一个有用预测因素。对于 CNR 较低的大 SMH 患者,当玻璃体切除术联合视网膜下组织纤溶酶原激活剂注射治疗困难时,单纯玻璃体腔 SF6 气体注射可能是一种治疗选择。